SCHEMBL12836705

SCHEMBL12836705

O=C(CCc1ccc(OC(F)(F)F)cc1)N1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
NAAA Q02083 1/20 0.57
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
MEN1 O00255 1/20 0.54
POLB P06746 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ENPP2 Q13822 1/20 0.53
ATXN2 Q99700 1/20 0.53
EPHX2 P34913 1/20 0.53
FKBP1A P62942 1/20 0.52
HRH3 Q9Y5N1 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12895459 0.99 NPC1 (0.57) NPC1TDP1NAAAALDH1A1LMNA
SCHEMBL13068970 0.88 ENPP2 (0.53) NPC1TDP1ENPP2ATXN2EPHX2
SCHEMBL17761198 0.85 ALDH1A1 (0.59) TDP1ALDH1A1LMNAHPGDMEN1
SCHEMBL19506302 0.84 HRH3 (0.67) NPC1HPGDSMN1; SMN2MEN1KMT2A
SCHEMBL16615993 0.82 ENPP2 (0.61) ALDH1A1MEN1KMT2AENPP2ATXN2
SCHEMBL25234683 0.81 ENPP2 (0.58) ALDH1A1MEN1KMT2AENPP2ATXN2
SCHEMBL16963832 0.81 ENPP2 (0.48) ALDH1A1POLBKMT2AENPP2ATXN2
SCHEMBL25234685 0.81 ENPP2 (0.58) ALDH1A1MEN1KMT2AENPP2ATXN2
SCHEMBL10305162 0.81 FKBP1A (0.76) NPC1TDP1NAAAALDH1A1LMNA
SCHEMBL22813668 0.81 HRH3 (0.67) NPC1TDP1NAAAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011034849-A1 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS AURIMED PHARMA, INC. (US) 2011-03-24 WO disclosed